Equities researchers at HC Wainwright boosted their FY2025 earnings per share (EPS) estimates for shares of Eyenovia in a note issued to investors on Thursday, February 6th. HC Wainwright analyst M.

Eyenovia (EYEN) announces recent progress on the development of its user-filled spray dispenser. “Millions of consumers have difficulty with ...

Eyenovia plans to submit for U.S. device regulatory approval in Q4 of this year, marking a key step toward ...

NEW YORK – Eyenovia, Inc., a pharmaceutical company specializing in preparations, announced today a reverse stock split of its common shares in a strategic move to comply with Nasdaq's minimum bid ...

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Reverse stock split, when effective, is intended to restore compliance with the Nasdaq minimum bid price requirement while Eyenovia continues to evaluate a broad range of strategic alternatives NEW ...

Eyenovia, Inc. (NASDAQ: EYEN) ("Eyenovia" or the "Company"), an ophthalmic technology company focused on completing development of its proprietary Optejet ...

The intelligent in-store audio platform is set to expand AI capabilities for audio ad creation, measurement and advanced audience targeting to help retailers boost in-store sales and turn on new ...

(NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its proprietary Optejet topical ophthalmic medication dispensing platform, today ...

Reverse stock split, when effective, is intended to restore compliance with the Nasdaq minimum bid price requirement while Eyenovia continues to evaluate a broad range of strategic alternatives ...